Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-09-03

Clinical Trial Update: Treatment of Nighttime Pruritus in Atopic Dermatitis [EARLY_Phase 1]

View source ↗

Summary

An early-phase clinical trial assessing treatment for nighttime pruritus in atopic dermatitis was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Nebraska | Conditions: Atopic Dermatitis | EARLY_Phase 1 | Status: WITHDRAWN